Loading...

Human TruStain FcX™ (Fc Receptor Blocking Solution)

Pricing & Availability
Regulatory Status
RUO
Other Names
Fc Blocker, FcγR blocker, Fc inhibitor
Ave. Rating
Submit a Review
Product Citations
publications
A_Human_TruStain_FcX_031110
Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant rat IgG2b PE mAb (above). Dotted histogram represents unstained cells.
  • C_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (filled histograms) or non-treated (open histograms) THP-1 cells stained with anti-human HLA-DR PE (red) or an isotype control (IgG2a PE, blue) mAbs. Note: non-treated cells show false-negative HLA-DR staining due to high binding of mouse IgG2a isotype.
Cat # Size Price Quantity Check Availability Save
422301 50 tests 81€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
422302 200 tests 184€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Human Fc receptors (FcRs) are expressed on a variety of cells, such as monocytes, granulocytes, B cells and dendritic cells. The cells with FcR expression sometimes give false positive or false negative results of immunofluorescent staining due to the FcRs-mediated Ig Fc binding. Human TruStain FcX™ is specially formulated for blocking the FcR-involved unwanted staining without interfering with antibody-mediated specific staining of human cells. Human TruStain FcX™ is compatible with flow cytometric staining with anti-human CD16 (clone 3G8), CD32 (clone FUN-2), and CD64 (clone 10.1) antibodies.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICFC, ICC - Reported in the literature, not verified in house
Recommended Usage

It is recommended to add 5 µl of Human TruStain FcX™ per million cells in 100 µl staining volume, mix and incubate at room temperature for 5-10 minutes prior to staining with antibody of interest. It is not necessary to wash cells between these blocking and immunostaining steps.

Application Notes

This buffer contains specialized human IgG in PBS containing 0.09% sodium azide. It is not recommended to be used for staining human IgG. Handle as biohazard agent.

Application References
  1. de la Cruz J, et al. 2011. J. Immunol. 186:2282. PubMed
  2. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  3. Szerlip NJ, et al. 2012. PNAS. 109:3041. PubMed
  4. Bromley SK, et al. 2013. J. Immunol. 190:970. PubMed
  5. Trujilo G, et al. 2013. J. Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Euzebio Alves VT, et al. 2013. Infect Immun. 81:4399. PubMed
  8. Borg ZD, et al. 2014. J. Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. PubMed
  10. Lines JL, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 23:802. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson ME Jr, et al. 2014. Otolaryngol Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong TT, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Klingenberg R, et al. 2015. Eur Heart J. 36:1041. PubMed
  24. Wilkinson-Ryan I, et al. 2015. PLoS One.10:125851. PubMed
Product Citations
  1. Klingenberg R, et al. 2014. Eur Heart J. . PubMed
  2. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  3. Simon A, et al. 2015. Blood. 126: 378 - 385. PubMed
  4. Mitton B, et al. 2016. Leukemia. 10.1038/leu.2016.139. PubMed
  5. Chen X, et al. 2019. Exp Ther Med. 1.265972222. PubMed
  6. Fisher RC, et al. 2019. Neoplasia. 1.061805556. PubMed
  7. Winkler CW, et al. 2019. J Neuroinflammation. 0.825694444. PubMed
  8. O'Huallachain M, et al. 2020. Commun Biol. 3:213. PubMed
  9. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  10. Bahri R, et al. 2020. Methods Mol Biol. 2163:227. PubMed
  11. Liu T, et al. 2020. Biochem Biophys Res Commun. 532:385. PubMed
  12. McIlwain DR, et al. 2021. Cell Host Microbe. 29:1828. PubMed
  13. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  14. Chang M, et al. 2022. Biotechnol Bioeng. 119:1820. PubMed
  15. Ioannidis LJ, et al. 2022. STAR Protoc. 3:101269. PubMed
  16. Glass MC, et al. 2022. Cell Rep. 39:110728. PubMed
  17. Mair F, et al. 2022. Nature. 605:728. PubMed
  18. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  19. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  20. Jang HJ, et al. 2022. Cancer Res. 82:2593. PubMed
  21. Campisi L, et al. 2022. Nature. 606:945. PubMed
  22. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  23. Neely J, et al. 2022. Front Immunol. 13:902232. PubMed
  24. Feyaerts D, et al. 2022. Cell Rep Med. 3:100680. PubMed
  25. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  26. Vazquez-Lombardi R, et al. 2022. Immunity. 55:1953. PubMed
  27. Calabrese DR, et al. 2022. JCI Insight. 7: . PubMed
  28. Scharf L, et al. 2023. JCI Insight. 8: . PubMed
  29. Messing M, et al. 2022. Front Immunol. 13:1010216. PubMed
  30. Wei H, et al. 2022. Front Immunol. 13:1060695. PubMed
  31. Wheeler MM, et al. 2022. Nat Commun. 13:7592. PubMed
  32. McEvoy CM, et al. 2022. Nat Commun. 13:7634. PubMed
  33. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  34. Kim JR, et al. 2022. Cancer Immunol Immunother. :. PubMed
  35. Wu VH, et al. 2023. Nat Immunol. 24:359. PubMed
  36. Stuart T, et al. 2022. Nat Biotechnol. :. PubMed
  37. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  38. Chow A 2023. Immunity. 56(1):93-106.e6. PubMed
  39. Asashima H, et al. 2023. Cell Rep. 42:111895. PubMed
  40. Sun W, et al. 2023. Nature. 614:309. PubMed
  41. Miller RA, et al. 2022. J Immunother Cancer. 10: . PubMed
  42. Heinen N, et al. 2023. Front Immunol. 13:1062210. PubMed
  43. Rice CM, et al. 2023. Life Sci Alliance. 6: . PubMed
  44. De Bakshi D, et al. 2023. Life Sci Alliance. 6: . PubMed
  45. Liao J, et al. 2023. Nat Commun. 14:207. PubMed
  46. Li Z, et al. 2022. J Thorac Dis. 14:4815. PubMed
  47. Poon MML, et al. 2023. Nat Immunol. 24:309. PubMed
  48. Wang CQ, et al. 2023. Cells. 12: . PubMed
  49. Mohamed H, et al. 2023. Biomedicines. 11: . PubMed
  50. Ty M, et al. 2023. Sci Transl Med. 15:eadd9012. PubMed
  51. Sadashivaiah V, et al. 2023. BMC Neurosci. 24:6. PubMed
  52. Gilman KE, et al. 2023. Front Immunol. 13:1045710. PubMed
  53. He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed
  54. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  55. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  56. Nandi I, et al. 2023. J Clin Invest. :. PubMed
  57. Chen SH, et al. 2022. Neurosci Bull. 38:290. PubMed
  58. Miller CL, et al. 2022. Cell Chem Biol. 29:451. PubMed
  59. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  60. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  61. Jaiswal A, et al. 2022. Cancer Cell. 40:524. PubMed
  62. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  63. Bednarski E, et al. 2022. MBio. 13:e0084022. PubMed
  64. Ferrall-Fairbanks MC, et al. 2022. Blood Cancer Discov. 3:536. PubMed
  65. Zhang X, et al. 2022. Cell Rep. 40:111363. PubMed
  66. Witkowski MT, et al. 2022. Nat Immunol. 23:1424. PubMed
  67. Gazinska P, et al. 2022. Clin Cancer Res. 28:4494. PubMed
  68. Li S, et al. 2022. Nature. 610:373. PubMed
  69. Xu Y, et al. 2022. Nat Genet. 54:1690. PubMed
  70. Ors A, et al. 2022. Nucleic Acids Res. 50:11492. PubMed
  71. Ainsua-Enrich E, et al. 2022. iScience. 25:105455. PubMed
  72. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  73. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  74. Bowley TY, et al. 2022. Cancer Res Commun. 2:1436. PubMed
  75. Imanishi M, et al. 2022. Front Cardiovasc Med. 9:988713. PubMed
  76. Ye D, et al. 2023. Cell Mol Neurobiol. 43:2337. PubMed
  77. Lai ZZ, et al. 2023. Front Immunol. 14:992765. PubMed
  78. Long D, et al. 2023. Eur J Immunol. 53:e2250109. PubMed
  79. Lareau CA, et al. 2023. Nat Protoc. 18:1416. PubMed
  80. Jun SH, et al. 2023. Nat Commun. 14:982. PubMed
  81. Ryan FJ, et al. 2023. Cell Rep Med. 4:100971. PubMed
  82. Lakkis J, et al. 2022. Nat Mach Intell. 4:940. PubMed
  83. Clark IC, et al. 2023. Nat Biotechnol. . PubMed
  84. Thaweerattanasinp T, et al. 2023. PeerJ. 11:e14918. PubMed
  85. Ishikawa M, et al. 2023. Front Immunol. 14:998233. PubMed
  86. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  87. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  88. Yao L, et al. 2022. Cancer Res Commun. 2:1255. PubMed
  89. Vasaikar SV, et al. 2023. Nat Commun. 14:1684. PubMed
  90. Persad S, et al. 2023. Nat Biotechnol. . PubMed
  91. Gao F, et al. 2023. Immunity. 56:864. PubMed
  92. Pinto C, et al. 2023. iScience. 26:106381. PubMed
  93. Im KW, et al. 2023. NPJ Breast Cancer. 9:22. PubMed
  94. Wu T, et al. 2023. Nat Methods. 20:723. PubMed
  95. Luo Y, et al. 2023. Cell Discov. 9:40. PubMed
  96. Jiang Y, et al. 2023. Sci Adv. 9:eadc8933. PubMed
  97. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  98. Woodley K, et al. 2023. Nat Commun. 14:2132. PubMed
  99. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  100. Thomas KA, et al. 2023. Transfusion. :S146. PubMed
  101. Boucher LE, et al. 2023. MAbs. 15:2195517. PubMed
  102. Lafôrets F, et al. 2023. iScience. 26:106514. PubMed
  103. Chen DY, et al. 2023. iScience. 26:106634. PubMed
  104. Solier S, et al. 2023. Nature. 617:386. PubMed
  105. Bera BS, et al. 2023. Epigenetics Chromatin. 16:14. PubMed
  106. Hu X, et al. 2023. Nat Biotechnol. . PubMed
  107. Luoma S, et al. 2023. Cancers (Basel). 15:. PubMed
  108. Lin W, et al. 2023. Commun Biol. 6:447. PubMed
  109. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  110. Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed
  111. Allard-Chamard H, et al. 2023. Cell Rep. 42:112630. PubMed
  112. Potts M, et al. 2023. Cell Rep. 42:112613. PubMed
  113. Diray-Arce J, et al. 2023. Cell Rep Med. 4:101079. PubMed
  114. Du J, et al. 2023. Nat Commun. 14:3675. PubMed
  115. Alber S, et al. 2022. Front Immunol. 13:838636. PubMed
  116. Wanke F, et al. 2017. Cell Rep. 18(5):1270-1284. PubMed
  117. Ecker JW, et al. 2020. Vaccines (Basel). 8:00. PubMed
  118. Liu C, et al. 2021. Cell. 184(7):1836-1857.e22. PubMed
  119. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  120. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  121. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  122. Lambert E, et al. 2022. Acta Neuropathol Commun. 10:4. PubMed
  123. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  124. Ptacin JL, et al. 2021. Nat Commun. 12:4785. PubMed
  125. Lau D, et al. 2022. Nat Commun. 13:4053. PubMed
  126. Sipe CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  127. Jackson S, et al. 2016. J Exp Med. 213: 733 - 750. PubMed
  128. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  129. Vuong T, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  130. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  131. Starlard–Davenport A, et al. 2019. Br J Haematol. 186:91. PubMed
  132. Wartewig T, et al. 2017. Nature. . 10.1038/nature24649. PubMed
  133. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  134. Jundi B, et al. 2021. JCI Insight. 6:e148866. PubMed
  135. Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
  136. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  137. Biasci D, et al. 2020. Proc Natl Acad Sci U S A. 117:28960. PubMed
  138. Glass DR, et al. 2020. Immunity. 53:217. PubMed
  139. Mehta P, et al. 2021. J Immunol. 207:1763. PubMed
  140. Lam B, et al. 2021. Cell Rep. 37:109838. PubMed
  141. de Cevins C, et al. 2021. Med (N Y). 2:1072. PubMed
  142. Gouin KH, et al. 2021. Nat Commun. 12:4906. PubMed
  143. Stanzione M, et al. 2022. Sci Adv. 8:eabn1229. PubMed
  144. Yoshida M, et al. 2022. Nature. 602:321. PubMed
  145. Egnuni T, et al. 2021. Pharmaceutics. 13:. PubMed
  146. Trujillo G, et al. 2013. J Immunol. 191:848. PubMed
  147. Karagiannis TT, et al. 2020. Nat Commun. 2.271527778. PubMed
  148. Raju R, et al. 2017. Stem Cells Dev. 26:274. PubMed
  149. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  150. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  151. Nielsen CM, et al. 2021. Cell Reports Medicine. 2(3):100207. PubMed
  152. Goveia J, et al. 2020. Cancer Cell. 21:37. PubMed
  153. Lee E, et al. 2021. Sci Rep. 11:14841. PubMed
  154. Doerflinger M, et al. 2021. Clin Transl Immunology. 10:e1235. PubMed
  155. Chen L, et al. 2021. Int J Mol Sci. 22:. PubMed
  156. Chen GM, et al. 2021. Cancer Discov. 11:2186. PubMed
  157. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  158. Rip J, et al. 2021. Bio Protoc. 11:e3902. PubMed
  159. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  160. Mylka V, et al. 2022. Genome Biol. 23:55. PubMed
  161. Jairaman A, et al. 2022. Elife. 11:. PubMed
  162. Takano T, et al. 2022. Cell Rep Med. 3:100631. PubMed
  163. Vinjamur DS, et al. 2021. Nat Genet. 53:719. PubMed
  164. Judge SJ, et al. 2022. Front Immunol. 13:893177. PubMed
  165. Lo MW, et al. 2022. Clin Transl Immunology. 11:e1413. PubMed
  166. Masuda K, et al. 2022. JCI Insight. 7:. PubMed
  167. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  168. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  169. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  170. Beljanski V, et al. 2015. J Virol. 89: 10612 - 10624. PubMed
  171. Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
  172. Feng WW, et al. 2019. Cell Rep. 29:3405. PubMed
  173. Li Z, et al. 2018. Exp Ther Med. 3.410416667. PubMed
  174. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  175. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  176. Gupta S, et al. 2020. Proc Natl Acad Sci U S A. 117:16481. PubMed
  177. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  178. Zhou WH, et al. 2022. Discov Oncol. 13:67. PubMed
  179. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
  180. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  181. Pérez-Pérez S, et al. 2022. Biomedicines. 10:. PubMed
  182. Figueroa-Romero C, et al. 2022. Front Immunol. 13:773288. PubMed
  183. Chen X, et al. 2022. Front Immunol. 12:807134. PubMed
  184. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  185. Snyder ME, et al. 2021. Am J Respir Crit Care Med. 203:1230. PubMed
  186. Jama B, Morris G 2014. J Vis Exp. 93: 52257. PubMed
  187. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  188. Al–Marsoummi S, et al. 2019. Cell Physiol Biochem. 53:999. PubMed
  189. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  190. Seamon K, et al. 2020. Front Immunol. 11:396. PubMed
  191. Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed
  192. Wang L, et al. 2022. Theranostics. 12:7216. PubMed
  193. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  194. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  195. Wang E, et al. 2021. Cell Stem Cell. 28(4):718-731.e6. PubMed
  196. Harris MJ, et al. 2021. Mol Syst Biol. 17:e10091. PubMed
  197. Liu C, et al. 2021. Cell Res. 31:1106. PubMed
  198. Pickering H, et al. 2021. JCI Insight. 6:. PubMed
  199. Nugent JL, et al. 2021. iScience. 24:103421. PubMed
  200. Chen Z, et al. 2022. J Nanobiotechnology. 20:30. PubMed
  201. Ogbe A, et al. 2022. JCI Insight. . PubMed
  202. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  203. Andrews JM, et al. 2021. EBioMedicine. 71:103559. PubMed
  204. Apostolidis SA, et al. 2022. Front Immunol. 13:834988. PubMed
  205. Woodruff MC, et al. 2022. Nature. :. PubMed
  206. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  207. Vir P, et al. 2015. PLoS One. 10: 0144904. PubMed
  208. Fuentes I, et al. 2020. Sci Rep. 10:15064. PubMed
  209. Stuart T, et al. 2019. Cell. 177:1888. PubMed
  210. Gao X, et al. 2017. PLoS One. 10.1371/journal.pone.0189167. PubMed
  211. Dashtsoodol N, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01206. PubMed
  212. Deng H, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1339-4. PubMed
  213. Kumar V, et al. 2022. Cells. 11:. PubMed
  214. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  215. Toulmin SA, et al. 2021. Nat Commun. 12:3993. PubMed
  216. Stephenson E, et al. 2021. Nat Med. 27:904. PubMed
  217. Layer JV, et al. 2020. Proc Natl Acad Sci U S A. 27566:117. PubMed
  218. Dogra P, et al. 2020. Cell. 749:180. PubMed
  219. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  220. Linke M, et al. 2017. Nat Immunol. 18:293-302. PubMed
  221. Burnett CE, et al. 2022. Immunity. 55:1284. PubMed
  222. Calianese D, et al. 2021. J Immunol. 207:436. PubMed
  223. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  224. Vijayakumar B, et al. 2022. Immunity. . PubMed
  225. Pérez-Pérez S, et al. 2021. Front Immunol. 12:798003. PubMed
  226. Chan JM, et al. 2021. Cancer Cell. 39:1479. PubMed
  227. Decker D, et al. 2014. Lupus. 123:2663. PubMed
  228. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  229. Busch S, et al. 2016. J Immunol. 197(11):4493-4503. PubMed
  230. Zhang W, et al. 2019. Exp Ther Med. 2.490972222. PubMed
  231. Bocharnikov AV, et al. 2019. JCI Insight. 4:e126832. PubMed
  232. Mair F, et al. 2020. Cell Rep. 31:107499. PubMed
  233. Worwa G, et al. 2022. Commun Biol. 5:1204. PubMed
  234. Bowen J, et al. 2017. PLoS Pathog. 13(2):e1006164. PubMed
  235. Kreutmair S, et al. 2021. Immunity. . PubMed
  236. Rapiteanu R, et al. 2020. Eur Respir J. :55. PubMed
  237. Harrison TE, et al. 2020. Nature. 309:587. PubMed
  238. Poonpanichakul T, et al. 2021. Front Immunol. 12:599805. PubMed
  239. Sen K, et al. 2021. Front Immunol. 12:733539. PubMed
  240. Zheng S, et al. 2022. Blood Cancer Discov. 3:103. PubMed
  241. Quinn TM, et al. 2022. EBioMedicine. 76:103856. PubMed
  242. Vanshylla K, et al. 2022. Cell Host Microbe. 30:69. PubMed
  243. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  244. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  245. Abrecht C, et al. 2022. STAR Protoc. 3:101362. PubMed
  246. Shen Z, et al. 2021. iScience. 24:103014. PubMed
  247. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  248. Qiu XM, et al. 2020. Reproduction. 251:159. PubMed
  249. Gonzalez VD, et al. 2021. Cell Reports. 36(9):109632. PubMed
  250. Obradovic A, et al. 2021. Cell. 184(11):2988-3005.e16. PubMed
  251. Russ K, et al. 2021. Cell Reports. 34(12):108895. PubMed
  252. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  253. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  254. Market M, et al. 2020. Front Immunol. 1.127083333. PubMed
  255. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  256. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  257. Lai ZZ, et al. 2020. Am J Reprod Immunol. 84:e13295. PubMed
  258. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  259. Romine KA, et al. 2021. Blood Cancer Discov. 2:518. PubMed
  260. Vanuytsel K, et al. 2022. Nat Commun. 13:1103. PubMed
  261. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  262. Muir LA, et al. 2022. JCI Insight. 7:. PubMed
  263. Romine KA, et al. 2021. Cancer Discov. . PubMed
  264. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  265. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  266. Borg Z, et al. 2014. J Immunol. 192:189. PubMed
  267. Shi J, et al. 2014. Blood. 123:4015. PubMed
  268. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  269. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  270. Zabransky DJ, et al. 2015. Proc Natl Acad Sci U S A. 112: 6205 -6214. PubMed
  271. Thorek D, et al. 2016. Sci Transl Med. 8: 367ra167. PubMed
  272. Souriant S, et al. 2019. Cell Rep. 26:3586. PubMed
  273. Riordon DR, et al. 2017. Methods Mol Biol. 1722:127. PubMed
  274. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  275. Le BV, et al. 2020. Cell Rep. 33:108221. PubMed
  276. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  277. Lu Q, et al. 2021. Immunity. 54(6):1304-1319.e9. PubMed
  278. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  279. Helmink BA, et al. 2020. Nature. 577:549. PubMed
  280. Cao Y, et al. 2021. Cell Res. 31:732. PubMed
  281. Wang W, et al. 2021. Clin Transl Med. 11:e253. PubMed
  282. Wang YC, et al. 2021. Nat Commun. 12:3530. PubMed
  283. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  284. Painter MM, et al. 2021. Immunity. 54:2133. PubMed
  285. Syrimi E, et al. 2021. iScience. 24:103215. PubMed
  286. Thijssen R, et al. 2022. Blood. :. PubMed
  287. Good Z, et al. 2022. Nat Med. :. PubMed
  288. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  289. Seifert L, et al. 2015. Cell Rep. 13: 1909-1921. PubMed
  290. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  291. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  292. Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed
  293. Opzoomer JW, et al. 2021. Elife. :10. PubMed
  294. Woodruff M, et al. 2020. medRxiv. . PubMed
  295. Nabet BY, et al. 2020. Cell. 183(2):363-376.e13. PubMed
  296. Zobel MJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  297. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  298. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  299. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  300. Jiang Y, et al. 2020. Br J Pharmacol. . PubMed
  301. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  302. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  303. Revelo X, et al. 2016. Cell Rep. 16: 717-730. PubMed
  304. Thomas K, et al. 2016. J Leukoc Biol. 100: 177 - 184. PubMed
  305. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  306. Studniberg SI, et al. 2022. Mol Syst Biol. 18:e10824. PubMed
  307. Huang Y, et al. 2022. iScience. 25:105209. PubMed
  308. Quintanal-Villalonga A, et al. 2022. STAR Protoc. 3:101776. PubMed
  309. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  310. Burns JC, et al. 2020. eLife. 9:00. PubMed
  311. Herati RS, et al. 2021. Cell Reports Medicine. 2(5):100262. PubMed
  312. Ziegler CGK, et al. 2021. Cell. 184(18):4713-4733.e22. PubMed
  313. An Y, et al. 2021. Sci Rep. 6392:11. PubMed
  314. Chen G, et al. 2021. Signal Transduct Target Ther. 6:289. PubMed
  315. Besnier M, et al. 2021. Antioxidants (Basel). 10:. PubMed
  316. Dugger DT, et al. 2021. Front Immunol. 12:704172. PubMed
  317. Vick SC, et al. 2021. Sci Adv. 7:eabj0274. PubMed
  318. Hu Y, et al. 2021. Am J Hum Genet. 108:874. PubMed
  319. Levi H, et al. 2022. J Exp Med. 219:. PubMed
  320. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  321. Trevelin SC, et al. 2022. Front Immunol. 13:838328. PubMed
  322. Sureshchandra S, et al. 2022. Cell Rep. 39:110938. PubMed
  323. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  324. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  325. Gadi D, et al. 2022. Leukemia. 36:723. PubMed
  326. Wang C, et al. 2015. Clin Immunol. 159: 47-57. PubMed
  327. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  328. Cruz J, et al. 2011. J Immunol. 186:2282. PubMed
  329. Reustle A, et al. 2022. Clin Transl Med. 12:e883. PubMed
  330. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  331. Wegner J, et al. 2021. Sci Rep. 11:14983. PubMed
  332. Sun L, et al. 2021. Sci Rep. 11:12477. PubMed
  333. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  334. OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed
  335. Cheng Y, et al. 2021. Immunity. 54(8):1825-1840.e7. PubMed
  336. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
  337. Zeng J, et al. 2020. Nat Med. 26:535. PubMed
  338. Bahcecioglu G, et al. 2021. Adv Sci (Weinh). 8:e2100128. PubMed
  339. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  340. Anadon CM, et al. 2022. STAR Protoc. 3:101649. PubMed
  341. Nadeu F, et al. 2022. Nat Med. 28:1662. PubMed
  342. Hirschberger S, et al. 2022. Front Med (Lausanne). 9:923502. PubMed
  343. Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed
  344. Wang J, et al. 2022. iScience. 25:103971. PubMed
  345. Wu Y, et al. 2022. J Cancer Res Clin Oncol. . PubMed
  346. Woolley CR, et al. 2022. Immunohorizons. 6:47. PubMed
  347. Wendisch D, et al. 2021. Cell. 184:6243. PubMed
  348. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  349. Poon MML, et al. 2021. Cell Rep. 37:110071. PubMed
  350. Tsuboki J, et al. 2016. Sci Rep. 6:29588. PubMed
  351. Gao M, et al. 2016. Sci Rep. 6:29955. PubMed
  352. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  353. Xue J, et al. 2020. Arthritis Res Ther. 1.070138889. PubMed
  354. Qin XH, et al. 2019. Langmuir. 35:1882. PubMed
  355. Song M, et al. 2018. Nature. 562:423. PubMed
  356. Cortés-López M, et al. 2022. Nat Commun. 13:5570. PubMed
  357. LaSalle TJ, et al. 2022. Cell Rep Med. 3:100779. PubMed
  358. Stephanie Elizabeth, Johanna Zandee 2017. Immunol Cell Biol. 10.1038/icb.2017.3. PubMed
  359. Morales Pantoja IE, et al. 2020. PLoS One. 15:e0233980. PubMed
  360. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  361. Still C 2nd, et al. 2021. Cell Reports Medicine. 2(7):100343. PubMed
  362. Feng W, et al. 2020. J Vis Exp. . PubMed
  363. Hannon E, et al. 2021. PLoS Genet. e1009443:17. PubMed
  364. Li YR, et al. 2021. Cell Rep Med. 2:100449. PubMed
  365. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  366. Kusi M, et al. 2022. Cell Rep. 38:110220. PubMed
  367. Dahal S, et al. 2022. Retrovirology. 19:18. PubMed
  368. Surendran N, et al. 2016. Innate Immunity. 22: 63 - 71. PubMed
  369. Lines J, et al. 2014. Cancer Res. 74:1924. PubMed
  370. Alves V, et al. 2013. Infect Immun . 81:4399. PubMed
  371. Ellyard JI, et al. 2019. Front Immunol. 1.898611111. PubMed
  372. Fan C, et al. 2019. Mol Med Rep. 3.002083333. PubMed
  373. Franco LM, et al. 2019. J Exp Med. 216:384. PubMed
  374. Oetjen KA, et al. 2018. JCI Insight. 3:e124928. PubMed
  375. Jiang X, et al. 2018. Cell Mol Immunol. 1.338194444. PubMed
  376. Gov L,et al. 2017. J Immunol. 10.4049/jimmunol.1700245. PubMed
  377. Metcalf T, et al. 2017. J Immunol. 10.4049/jimmunol.1700148. PubMed
  378. Huang D, et al. 2022. Cell Discov. 8:121. PubMed
  379. Paul S, et al. 2021. Sci Transl Med. 13:. PubMed
  380. Combes AJ, et al. 2021. Nature. 591:124. PubMed
  381. Larson-Casey JL, et al. 2020. PLoS One. 15:e0241323. PubMed
  382. Carmona-Rivera C, et al. 2020. JCI Insight. 5:00. PubMed
  383. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  384. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  385. Lo YC, et al. 2022. Nat Commun. 13:934. PubMed
  386. Thakkar D, et al. 2022. J Immunother Cancer. 10:. PubMed
  387. Erickson JR, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  388. Wang X, et al. 2022. J Immunol. 208:396. PubMed
  389. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  390. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  391. Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
  392. Wanke-Jellinek L, et al. 2016. J Immunol. 196: 767 - 777. PubMed
  393. Schneeberger V, et al. 2016. PLoS One. 11: 0160587. PubMed
  394. Maini A, et al. 2016. PLoS One. 11:e0165502. PubMed
  395. Burel J, et al. 2016. PLoS Negl Trop Dis. 10:e0005031. PubMed
  396. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  397. Nobre LV, et al. 2020. eLife. 8:e49894.. PubMed
  398. Szerlip N, et al. 2012. Proc Natl Acad Sci U S A. 109:3041. PubMed
  399. Bromley S, et al. 2013. J Immunol. 190:970. PubMed
  400. Guo JJ, et al. 2017. Exp Ther Med. 3.842361111. PubMed
  401. López-Sanz C, et al. 2022. STAR Protoc. 3:101755. PubMed
  402. Kirabo A, et al. 2017. J Mol Cell Cardiol. 10.1016/j.yjmcc.2017.03.001. PubMed
  403. Judge SJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  404. Greenlee JD, et al. 2021. eLife. 0.416666666666667. PubMed
  405. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  406. Hepprich M, et al. 2020. Cell Metab. 699:31. PubMed
  407. Demaree B, et al. 2021. Nat Commun. 1583:12. PubMed
  408. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  409. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  410. Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed
  411. Liao M, et al. 2021. Aging (Albany NY). 13:22412. PubMed
  412. Gutierrez C, et al. 2021. Nat Cancer. 2:758. PubMed
  413. Georg P, et al. 2022. Cell. 185:493. PubMed
  414. Céspedes PF, et al. 2022. Nat Commun. 13:3460. PubMed
  415. Zhang F, et al. 2021. Genome Med. 13:64. PubMed
  416. Luque-Martin R, et al. 2021. J Immunol. 207:555. PubMed
  417. Li F, et al. 2022. Nat Commun. 13:4334. PubMed
  418. Rydyznski Moderbacher C, et al. 2022. J Clin Invest. :. PubMed
  419. Hwang B, et al. 2021. Nat Methods. 18:903. PubMed
  420. Montel-Hagen A, et al. 2022. Curr Protoc. 2:e403. PubMed
  421. Nahid M, et al. 2016. J Leukoc Biol. 100: 339 - 349. PubMed
  422. Eichten A, et al. 2016. Cancer Res . 76: 2327-2339. PubMed
  423. Wierzbinska JA, et al. 2020. Genome Med. 12:29. PubMed
  424. Bricio–Moreno L, et al. 2018. Nat Commun. 2.204861111. PubMed
  425. Arrigucci R, et al. 2017. Nat Protoc. 1.364583333. PubMed
  426. Strazza M, et al. 2022. Mol Ther Methods Clin Dev. 27:380. PubMed
  427. Konkimalla A, et al. 2022. iScience. 25:105114. PubMed
  428. Yang Y, et al. 2021. Emerg Microbes Infect. 10:905. PubMed
  429. Shuwa HA, et al. 2021. Med. 2(6):720-735.e4. PubMed
  430. Landgraf KE, et al. 2020. Commun Biol. 0.330555556. PubMed
  431. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  432. Liu Y, et al. 2022. Clin Transl Med. 12:e654. PubMed
  433. Ruan LY, et al. 2022. Biomolecules. 12:. PubMed
  434. Lederer K, et al. 2022. Cell. . PubMed
  435. Wang YM, et al. 2022. Oncoimmunology. 11:2034257. PubMed
  436. Jiang J, et al. 2021. Front Immunol. 12:785549. PubMed
  437. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  438. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  439. Wilkinson-Ryan I, et al. 2015. PLoS One. 10:125851. PubMed
  440. Ali A, et al. 2015. PLoS One. 10: 0131645. PubMed
  441. Kanzaki H, et al. 2016. Sci Rep. 6:32259. PubMed
  442. Goehring K, et al. 2016. J Nutr. 146(12):2559-2566. PubMed
  443. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  444. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  445. Kubala MH, et al. 2018. Cell Rep. 25:2177. PubMed
  446. Delgado-Gonzalez A, et al. 2022. STAR Protoc. 3:101425. PubMed
  447. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  448. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  449. Maehara T, et al. 2020. J Clin Invest. 130:2451. PubMed
  450. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  451. Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed
  452. Jin HS, et al. 2020. Cancer Immunol Res. 8:912. PubMed
  453. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  454. Rovira-Clavé X, et al. 2021. Nat Commun. 12:4628. PubMed
  455. Wurm M, et al. 2021. Mol Cancer Ther. 20:2250. PubMed
  456. Pauken CM, et al. 2021. Cancers (Basel). 13:. PubMed
  457. Genge PC, et al. 2021. STAR Protoc. 2:100900. PubMed
  458. Winkler C, et al. 2021. JCI Insight. 6:. PubMed
  459. Adamo S, et al. 2022. Nature. 602:148. PubMed
  460. Krijgsman D, et al. 2022. STAR Protoc. 3:101034. PubMed
  461. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  462. Konishi S, et al. 2022. STAR Protoc. 3:101447. PubMed
  463. Galván-Peña S, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  464. Wilson TL, et al. 2022. Cancer Discov. 12:2098. PubMed
  465. Claireaux MAF, et al. 2022. Nat Commun. 13:4539. PubMed
  466. Allard-Chamard H, et al. 2021. J Immunol. 206:524. PubMed
  467. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  468. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  469. Nielsen S, et al. 2016. Nat Cell Biol. 18: 549-560. PubMed
  470. Jarantow S, et al. 2015. J Biol Chem. 290: 24689 - 24704. PubMed
  471. Anderson M, et al. 2014. Otolaryngology Head Neck Surg. 150:880. PubMed
  472. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  473. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  474. Cai Q, et al. 2019. Oncol Lett. 2.967361111. PubMed
  475. Yang ZZ, et al. 2019. Cell Rep. 26:2178. PubMed
  476. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  477. Manríquez V, et al. 2021. Nat Commun. 12:4547. PubMed
  478. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  479. Salahudeen AA, et al. 2020. bioRxiv. . PubMed
  480. Qi J, et al. 2021. Cell Reports Medicine. 2(8):100353. PubMed
  481. Hara T, et al. 2021. Cancer Cell. 39(6):779-792.e11. PubMed
  482. Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
  483. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  484. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  485. Alhussan A, et al. 2022. Cancers (Basel). 14:. PubMed
  486. Lee PC, et al. 2022. J Clin Invest. 132:. PubMed
  487. Rouhani SJ, et al. 2022. J Immunother Cancer. 10:. PubMed
  488. Chan M, et al. 2021. Mol Syst Biol. 17:e10426. PubMed
  489. Rodríguez-Lorenzo S, et al. 2022. Elife. 11:. PubMed
  490. Pleguezuelos O, et al. 2015. Clin Vaccine Immunol. 22: 828 - 835. PubMed
  491. Alasoo K, et al. 2015. Sci Rep. 5: 12524. PubMed
  492. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  493. Verma SK, et al. 2018. J Biol Chem. 293:254. PubMed
  494. Lynskey N, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006493. PubMed
  495. Eitas T, et al. 2017. PLoS One. 10.1371/journal.pone.0184164. PubMed
  496. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  497. MacBride M, et al. 2017. Mammalian Genome. 10.1007/s00335-017-9680-0. PubMed
  498. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  499. Nistler R, et al. 2020. Immunohorizons. 0.397222222. PubMed
  500. Pettmann J, et al. 2021. eLife. 10:00. PubMed
  501. Luoma AM, et al. 2020. Cell. 182(3):655-671.e22. PubMed
  502. Perugino CA, et al. 2021. J Allergy Clin Immunol. 368:147. PubMed
  503. Shaw BC, et al. 2021. CRISPR J. 4:699. PubMed
  504. Chen C, et al. 2022. iScience. 25:103645. PubMed
  505. Lu J, et al. 2022. STAR Protoc. 3:101559. PubMed
  506. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  507. Wolf J, et al. 2016. J Biol Chem. 291: 16186 - 16196. PubMed
  508. Schneck H, et al. 2015. PLoS One. 10: 0144535. PubMed
  509. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  510. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  511. Itoh H, et al. 2017. J Vet Med. 10.1155/2017/5701016. PubMed
  512. Kamada R, et al. 2017. The Journal of Biochemistry. 10.1093/jb/mvx032. PubMed
  513. Yao W, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.017. PubMed
  514. Jeong HO, et al. 2022. iScience. 25:105358. PubMed
  515. Murphy DM, et al. 2022. J Clin Invest. Online ahead of print. PubMed
  516. Kämpe A, et al. 2021. PLoS One. 16:e0257442. PubMed
  517. Pinto SM, et al. 2021. Front Immunol. 12:679458. PubMed
  518. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
  519. Wang EY, et al. 2021. Nature. 595:283. PubMed
  520. Mpakou V, et al. 2021. Exp Ther Med. 1.010416667. PubMed
  521. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  522. Sainson RCA, et al. 2020. Cancer Immunol Res. 1.422222222. PubMed
  523. Salahudeen AA, et al. 2020. Nature. 588:670. PubMed
  524. Okamura Y, et al. 2017. Allergol Int. 10.1016/j.alit.2017.03.002. PubMed
  525. Faissner S, et al. 2022. Front Immunol. 13:980526. PubMed
  526. Zha Y, et al. 2022. Front Immunol. 13:877314. PubMed
  527. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  528. Medeiros-Furquim T, et al. 2022. Front Immunol. 13:678817. PubMed
  529. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
RRID
AB_2818986 (BioLegend Cat. No. 422302)

Antigen Details

Molecular Family
Fc Receptors
Gene ID
NA

Related FAQs

Is our human Trustain FcX™ (cat# 422302) compatible with anti human CD16, CD32 and CD64 clones 3G8, FUN-2 and 10.1 respectively?

Yes

What is the concentration of Human TruStain FcX™ (Fc receptor blocking solution, Cat#422301)?
This information is proprietary.
Go To Top Version: 4    Revision Date: 07/14/2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account